Correlation Between BioPorto and Ascelia Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioPorto and Ascelia Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioPorto and Ascelia Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioPorto and Ascelia Pharma AB, you can compare the effects of market volatilities on BioPorto and Ascelia Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioPorto with a short position of Ascelia Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioPorto and Ascelia Pharma.

Diversification Opportunities for BioPorto and Ascelia Pharma

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between BioPorto and Ascelia is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding BioPorto and Ascelia Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascelia Pharma AB and BioPorto is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioPorto are associated (or correlated) with Ascelia Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascelia Pharma AB has no effect on the direction of BioPorto i.e., BioPorto and Ascelia Pharma go up and down completely randomly.

Pair Corralation between BioPorto and Ascelia Pharma

Assuming the 90 days trading horizon BioPorto is expected to generate 0.56 times more return on investment than Ascelia Pharma. However, BioPorto is 1.77 times less risky than Ascelia Pharma. It trades about 0.0 of its potential returns per unit of risk. Ascelia Pharma AB is currently generating about 0.0 per unit of risk. If you would invest  238.00  in BioPorto on September 13, 2024 and sell it today you would lose (66.00) from holding BioPorto or give up 27.73% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.6%
ValuesDaily Returns

BioPorto  vs.  Ascelia Pharma AB

 Performance 
       Timeline  
BioPorto 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioPorto has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Ascelia Pharma AB 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Ascelia Pharma AB are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating technical and fundamental indicators, Ascelia Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

BioPorto and Ascelia Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioPorto and Ascelia Pharma

The main advantage of trading using opposite BioPorto and Ascelia Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioPorto position performs unexpectedly, Ascelia Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascelia Pharma will offset losses from the drop in Ascelia Pharma's long position.
The idea behind BioPorto and Ascelia Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Transaction History
View history of all your transactions and understand their impact on performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation